Autoimmune hepatitis associated Hepatitis C virus infection treated with fi rst generation direct-acting antivirals

<p>The hepatitis C virus (HCV) infection has been associated with autoimmune diseases, probably due to the interaction between HCV E2 envelope protein and CD-81 receptor of B lymphocyte and thus, can infl uence the pathogenesis of autoimmune liver diseases [1,2]. Therefore, it seems reasonable...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Diego Castro Limo (Author), Tomas Artaza Varasa (Author), Maria Recuero Pradillo (Author), Marta Romero-Gutierrez (Author), Ana Zaida Gomez Moreno (Author), Juan Jose Sanchez Ruano (Author), Carlos San Roman Gutierrez (Author), Pablo Munoz Gomez (Author), Rafael Gomez Rodríguez (Author)
Format: Book
Published: Annals of Antivirals and Antiretrovirals - Peertechz Publications, 2019-10-04.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_aaa_000006
042 |a dc 
100 1 0 |a Juan Diego Castro Limo  |e author 
700 1 0 |a  Tomas Artaza Varasa  |e author 
700 1 0 |a  Maria Recuero Pradillo  |e author 
700 1 0 |a  Marta Romero-Gutierrez  |e author 
700 1 0 |a  Ana Zaida Gomez Moreno  |e author 
700 1 0 |a  Juan Jose Sanchez Ruano  |e author 
700 1 0 |a  Carlos San Roman Gutierrez  |e author 
700 1 0 |a  Pablo Munoz Gomez  |e author 
700 1 0 |a Rafael Gomez Rodríguez  |e author 
245 0 0 |a Autoimmune hepatitis associated Hepatitis C virus infection treated with fi rst generation direct-acting antivirals 
260 |b Annals of Antivirals and Antiretrovirals - Peertechz Publications,   |c 2019-10-04. 
520 |a <p>The hepatitis C virus (HCV) infection has been associated with autoimmune diseases, probably due to the interaction between HCV E2 envelope protein and CD-81 receptor of B lymphocyte and thus, can infl uence the pathogenesis of autoimmune liver diseases [1,2]. Therefore, it seems reasonable to consider the benefi cial effect of direct-acting antivirals (DAAs) for HCV in patients with chronic HCV infection and autoimmune hepatitis (HAI), although evidence is scarce. We report the case of an HCV-infected patient who developed an HAI triggered by interferon and since then has been treated with DAAs improving liver function and maintaining sustained virologic response (SVR), without immunosuppressive treatment nowadays.</p> 
540 |a Copyright © Juan Diego Castro Limo et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/aaa.000006  |z Connect to this object online.